Sleep medicine

Sleep Specialist and Otolaryngologist, Julie Zweig, M.D., is Featured as a 2024 Top Patient Rated Doctor by Find Local Doctors

Retrieved on: 
Monday, March 11, 2024
Sleep, Sleep apnea, Hormone, Patient, Insomnia, Sleep medicine, University, MD, Ear, Suite, ENT, Patient satisfaction, Nasal congestion, Hearing loss, Kool-Aid, Medicine, Nose, Allergy, Multimedia, Physician, Hearing, Pharmaceutical industry

ALPHARETTA, Ga., March 11, 2024 /PRNewswire-PRWeb/ -- Dr. Julie Zweig, a renowned, board-certified ear nose and throat (ENT) and sleep medicine physician, has been recognized as a 2024 Top Patient Rated Otolaryngologist by Find Local Doctors. This prestigious title is awarded to practices that have received an exceptional number of five-star ratings and superior reviews from satisfied patients. Find Local Doctors, a trusted online directory, is dedicated to helping consumers find reputable physicians in their area. The recognition bestowed upon Dr. Zweig and her team is a testament to their commitment to providing top-notch care and achieving outstanding patient satisfaction.

Key Points: 
  • ALPHARETTA, Ga., March 11, 2024 /PRNewswire-PRWeb/ -- Dr. Julie Zweig, a renowned, board-certified ear nose and throat (ENT) and sleep medicine physician, has been recognized as a 2024 Top Patient Rated Otolaryngologist by Find Local Doctors.
  • Find Local Doctors , a trusted online directory, is dedicated to helping consumers find reputable physicians in their area.
  • Julie Zweig, MD Integrative Sleep & ENT is located at 2650 Holcomb Bridge Road, Suite 510 in Alpharetta, Georgia.
  • Dr. Julie Zweig, Julie Zweig, MD Integrative Sleep & ENT, 404-255-4080, [email protected] , https://juliezweigmd.com/
    View original content to download multimedia: https://www.prweb.com/releases/sleep-specialist-and-otolaryngologist-jul...

Axsome Therapeutics Hosts Solriamfetol Virtual Investor Event with Expert Thought Leaders Today

Retrieved on: 
Thursday, December 7, 2023
Sleep medicine, Psychiatry, Attention deficit hyperactivity disorder, Obstructive sleep apnea, Eastern Time Zone, Division, Binge eating disorder, TAAR1, Psychopharmacology, BED, SHARP, Medical school, DSM-IV codes, MD, Doctor of Philosophy, Research, Therapy, University, HOPE, Associate, EDS, CNS, Narcolepsy, OSA, Webcast, Central nervous system, MDD, Patient, ADHD, Harvard Medical School, Dopamine, SWD

At the event, invited physician thought leaders will discuss current and potential future indications.

Key Points: 
  • At the event, invited physician thought leaders will discuss current and potential future indications.
  • The Axsome senior leadership team will provide an overview of clinical development plans.
  • Expert thought leaders presenting at the event include:
    Craig Chepke, MD, Medical Director of Excel Psychiatric Associates in Huntersville, N.C. and Adjunct Associate Professor of Psychiatry for Atrium Health.
  • A replay of the webcast will be available for approximately 30 days following the live event.

BioIntelliSense and UC Davis Health Launch Continuous Monitoring Program for Bone Marrow Transplant Patients

Retrieved on: 
Thursday, November 16, 2023
Wearables, Mobile Technology, Biometrics, Other Health, Artificial Intelligence, Oncology, Software, Medical Devices, Hardware, Hospitals, Professional Services, Technology, General Health, Biotechnology, Data Analytics, Surgery, Health, University, Health Technology, Education, Risk, Respiratory rate, Patient, Sleep medicine, Rest, FDA, CIO, Digital, MD, Skin temperature, University of California, Davis, News, Vital signs, Critical care, UC, UC Davis Health Stadium, Medical imaging, Nursing, Pharmaceutical industry

BioIntelliSense , a continuous health monitoring and clinical intelligence company, and California-based UC Davis Health announce the launch of a new in-hospital monitoring initiative for patients hospitalized for Bone Marrow Transplant and Hematology/Oncology services.

Key Points: 
  • BioIntelliSense , a continuous health monitoring and clinical intelligence company, and California-based UC Davis Health announce the launch of a new in-hospital monitoring initiative for patients hospitalized for Bone Marrow Transplant and Hematology/Oncology services.
  • “Smart care is the future of healthcare, and we are delivering on that promise with the introduction of this continuous care program at UC Davis Health.”
    An award-winning academic medical center, UC Davis Health is a recognized leader in advancing digital transformation initiatives focused on equitable, accessible, and cost-effective patient care.
  • The BioIntelliSense project has been led and driven by the cutting-edge UC Davis Health Digital CoLab and their commitment to identifying, evaluating, and implementing best-in-class technologies and programs.
  • “We want to empower our clinical teams with the most advanced tools available, so they can effectively and efficiently personalize every patient’s care.

Jazz Pharmaceuticals to Present Latest Advancements in Sleep Medicine at World Sleep 2023

Retrieved on: 
Wednesday, October 18, 2023
Jazz Pharmaceuticals, Stroke, Splenic infarction, Sleep disorder, Sodium, MSCE, Literature, Blood pressure, Sleep medicine, Congress, Narcolepsy, Prevalence, Idiopathic hypersomnia, Systematic review, Research, Sleep, Magnesium, Sodium oxybate, SEGUE, Abstract, Cancer, CV, Patient, Calcium, Potassium, Heart failure, Medicine, Cardiovascular disease, Nightclub, Pharmaceutical industry, MD

DUBLIN, Oct. 18, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company and its partners will present 14 abstracts from across its sleep medicine portfolio, including two oral presentations, at the 17th annual World Sleep 2023 Congress, held October 20-25 in Rio de Janeiro, Brazil.

Key Points: 
  • DUBLIN, Oct. 18, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company and its partners will present 14 abstracts from across its sleep medicine portfolio, including two oral presentations, at the 17th annual World Sleep 2023 Congress, held October 20-25 in Rio de Janeiro, Brazil.
  • The oral presentations include findings from the real-world TENOR study, which demonstrated individualized dosing strategies for twice-nightly oxybate treatment in narcolepsy.
  • The World Sleep 2023 schedule is available online and outlines all abstracts, posters and oral presentations slated to be shared at the congress.
  • All abstracts are published in a supplemental issue of Sleep Medicine, the official journal of World Sleep Society, two months after the event.

Florida Physician ACO, Millennium Physician Group, Taps REMware for Sleep Apnea Testing Services

Retrieved on: 
Monday, October 9, 2023
Technology, Medical Devices, Diabetes, Fitness & Nutrition, Health Technology, Software, Other Health, Alternative Medicine, Health, Cardiovascular disease, Hypertension, Sleep medicine, Obstructive sleep apnea, Disease, Type 2 diabetes, Central sleep apnea, Immune system, Depression, Sleep, Sleep apnea, ER, Patient, Pharmaceutical industry, Hospital, MD

Millennium Physician Group , an independent physician group practicing in Florida, Texas and North Carolina, announced they have selected sleep technology company REMware™ to provide home sleep apnea testing services through their more than 750 health care providers.

Key Points: 
  • Millennium Physician Group , an independent physician group practicing in Florida, Texas and North Carolina, announced they have selected sleep technology company REMware™ to provide home sleep apnea testing services through their more than 750 health care providers.
  • REMware is the developer of a home sleep testing patented process, called DreamClear™, that simplifies and accelerates the entire diagnostic process to meet the escalating demand to detect and treat undiagnosed sleep apnea.
  • “Approximately 42% of Americans have one or more chronic diseases that have a strong comorbid association to undiagnosed or untreated obstructive sleep apnea,” said REMware CEO Arun Ramabadran.
  • “Addressing sleep apnea improves value-based metrics at a lower cost, especially related to expensive health issues such as cardiovascular disease, hypertension, Type 2 diabetes and depression.

New Research Demonstrates Clinical Effectiveness of Digital Treatment at Improving Insomnia and Comorbid Mental and Physical Health Issues

Retrieved on: 
Monday, October 9, 2023
Page, Doctor of Philosophy, Anxiety, Cognitive behavioral therapy, Cerebrovascular disease, Sleep, Sleep medicine, Nation, Therapy, Psychology, Ageing, University, Dave's Picks Volume 38, Digital, Comorbidity, Disease, Cancer, Randomized controlled trial, Brain damage, Spectrum, Insomnia, Meta-analysis, DSM-IV codes, Journal of Affective Disorders, Research, Depression, SAN, Survivor, RCT, CBT, Nuffield Department of Population Health, ASCO, WSO, PMID, Disability, Systematic review, Canadian International Council, PMCID, Neurorehabilitation and Neural Repair, University of Oxford, Patient, Pharmaceutical industry, Nursing, Dietary supplement, Sleepio, Stroke

SAN FRANCISCO and OXFORD, England, Oct. 9, 2023 /PRNewswire-PRWeb/ -- Big Health, the leader in digital therapeutics for the most common mental health conditions, announced today the publication of two, peer-reviewed studies demonstrating the effects of its flagship digital insomnia treatment Sleepio in individuals with co-morbid insomnia and clinically significant anxiety as well as in stroke survivors. 

Key Points: 
  • Digital cognitive behavioral therapy (dCBT) has long been evidenced as an effective treatment for insomnia and anxiety — key findings from these studies provide new insights into Sleepio's impact.
  • In a separate study among stroke survivors, 71% achieved remission using Sleepio compared to 30% of control participants.
  • Individuals with insomnia are three times more likely to develop anxiety than healthy sleepers.
  • [1] Additionally, comorbid insomnia and anxiety are associated with greater severity of both conditions — as well as increased symptoms of depression and poorer physical health.

National Sleep Foundation Reinforces Consistent Sleep Schedules with New Consensus Guideline

Retrieved on: 
Thursday, September 7, 2023
Consensus, Obesity, Bureau of Oceans and International Environmental and Scientific Affairs, Diabetes, Life, Cone Health Women's Hospital, NSF, Cardiovascular disease, Cancer, Inflammation, Doctor of Philosophy, Science, Harvard Medical School, Journal, MD, Guideline, National Sleep Foundation, Sleep medicine, DSM-IV codes, Nobel, Hospital, Health, Mental health, Nursing, Sleep, Research

WASHINGTON, Sept. 7, 2023 /PRNewswire/ -- The National Sleep Foundation (NSF) issued a new guideline emphasizing the benefit of consistent sleep schedules on health and performance. The results are from a consensus report published in Sleep Health®, the Journal of the National Sleep Foundation, under the original title The importance of sleep regularity: a consensus statement of the National Sleep Foundation sleep timing and variability panel.

Key Points: 
  • Features evidence-based benefits for health and performance,
    WASHINGTON, Sept. 7, 2023 /PRNewswire/ -- The National Sleep Foundation (NSF) issued a new guideline emphasizing the benefit of consistent sleep schedules on health and performance.
  • The results are from a consensus report published in Sleep Health®, the Journal of the National Sleep Foundation, under the original title The importance of sleep regularity: a consensus statement of the National Sleep Foundation sleep timing and variability panel .
  • NSF established an expert panel of some of the foremost authorities in sleep and circadian science to develop a consensus recommendation for consistent sleep schedules, reflecting an extensive analysis of the peer-reviewed literature on the subject.
  • "Maintaining consistent sleep and wake times and utilizing non-work days to help catch-up on sleep are two tools most members of the public can use to promote sleep health."

Synthpop Secures $2.6 Million in Seed Funding and Unveils a Connected System of Artificial Intelligence (AI) Assistants for Healthcare Providers

Retrieved on: 
Tuesday, August 22, 2023
Stanford University, Synth-pop, EMR, Health care, Privacy, Multimedia, Sleep medicine, Entrepreneurship, Remote patient monitoring, AI, Roger Hawkins (drummer), Medical device, Pharmaceutical industry, Cryptocurrency

WELLESLEY, Mass., Aug. 22, 2023 /PRNewswire/ -- Synthpop is pleased to announce its recent product launch - a new connected system of AI assistants for Healthcare workflow automation.

Key Points: 
  • WELLESLEY, Mass., Aug. 22, 2023 /PRNewswire/ -- Synthpop is pleased to announce its recent product launch - a new connected system of AI assistants for Healthcare workflow automation.
  • Synthpop's AI assistants are fine-tuned using existing medical data: this solution is HIPAA-compliant, and exceptionally accurate out-of-the-box, eliminating the need for lengthy integrations.
  • Synthpop's AI assistants are fine-tuned using existing medical data: this solution is HIPAA-compliant, and accurate out-of-the-box, eliminating the need for lengthy integrations.
  • Our goal is to make our healthcare system faster, more efficient, and eventually, more patient-centric," shared Elad Ferber, CEO and Co-Founder.

Sleep Medicine Expert Dr. Marc Benton Joins BetterNight as Staff Doctor to Expand Footprint in New Jersey

Retrieved on: 
Tuesday, August 8, 2023
Madison, Physician, Summit Health, American Academy, American Thoracic Society, Mount Sinai School District, American Academy of Sleep Medicine, Patient, SAN, Sleep medicine, American College of Chest Physicians, American College, Sleep, Clinical, Castle Connolly Medical, Nursing

Dr. Marc Benton is an esteemed medical professional recognized as a Top Doctor by New Jersey Magazine and Castle-Connolly every year since 2001.

Key Points: 
  • Dr. Marc Benton is an esteemed medical professional recognized as a Top Doctor by New Jersey Magazine and Castle-Connolly every year since 2001.
  • Dr. Benton is also a fellow of the American Academy of Sleep Medicine and a member of the American Thoracic Society.
  • As a Staff Doctor with BetterNight, Dr. Benton will play a key role in expanding BetterNight's footprint in New Jersey, "I am excited to join BetterNight and help them make a positive impact on the sleep health of New Jersey residents," said Dr. Benton.
  • "We are thrilled to have Dr. Benton join our team as a Staff Doctor," said David French, CEO of BetterNight.

Max Hirshkowitz, PhD, Receives National Sleep Foundation's Lifetime Achievement Award

Retrieved on: 
Monday, May 1, 2023
Consensus, BPS Barbara Wilson Lifetime Achievement Award, Polysomnography, Consumer Technology Association, NSF, Sleep, Baylor University, National Sleep Foundation, CTA, Michael E. DeBakey Veterans Affairs Medical Center in Houston, Research, Doctor of Philosophy, Sleep Research Society, Insomnia, Stanford University School of Medicine, Public health, Sleep medicine, Chairperson, Obstructive sleep apnea, NIH, Chair, Pharmaceutical industry, Nursing

WASHINGTON, May 1, 2023 /PRNewswire/ -- National Sleep Foundation (NSF) announced today that Max Hirshkowitz, PhD, has received its Lifetime Achievement Award.

Key Points: 
  • WASHINGTON, May 1, 2023 /PRNewswire/ -- National Sleep Foundation (NSF) announced today that Max Hirshkowitz, PhD, has received its Lifetime Achievement Award.
  • The Lifetime Achievement Award is the organization's highest honor, recognizing an individual who has demonstrated exemplary leadership in the field of sleep health.
  • He has authored hundreds of peer-reviewed articles and served on the editorial board of multiple journals including Sleep Health, Sleep Medicine, and Sleep Research.
  • To learn more about the National Sleep Foundation's Lifetime Achievement Award, visit the NSF website .